About Integene International

About company

Integene International LLC. is a privately held Florida Corporation. The Company has developed platform technology for diabetes and it's complications. Targets include Peripheral Artery Disease (PAD) Obesity and Hyperglycemia. Integene International has developed a unique protocol GenstemX for the treatment of Ischemic diseases. Primary patented treatment is for Criticial Lower Limb Ischemia (CLI). The combined gene and stem cell treatment has proven successful in pre-clinical testing.